The role of disaccharide complexes in triggering programmed cell death in cancer cells MCF-7 and HeLa
Keywords:
apoptosis, cancer, cellobiose complex, cytotoxicity, natural compounds, necrosisAbstract
Previous in vitro studies have confirmed that exposure of human endothelial cells to high glucose concentration induces significant cell death via apoptosis. The present studies therefore explore the options for treating cancer with cellobiose complex and natural compounds containing disaccharides. Our results show that the cellobiose complex containing cellobiose with vitamin C, sulphur and selenium isolated from a mixture of two cold plant extracts Capsicum chinense and Allium sativum induces cell death in HeLa cancer cells by activating caspase-3 and loss of mitochondrial integrity, but not in MCF-7 cancer cells or the immortalized cell line HaCaT. When we treated HeLa cancer cells with the laboratory-produced cellobiose alone, we found that a 10,000 x higher concentration was needed (100 mg/mL - 1,000 mg/mL), suggesting the important synergistic role of the other mentioned molecules in the complex, which enable the molecule of cellobiose to be more effective at lower dosages. This study therefore for the first time suggests that the complex formed of cellobiose, selenium, sulphur and vitamin C has an apoptotic and necrotic effect, which could be due to the modulation of a mitochondria-mediated intrinsic apoptotic pathway.Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.